Dysregulated MicroRNAs in Parkinson’s Disease: Pathogenic Mechanisms and Biomarker Potential
International Journal of Molecular Sciences · 17.01.2026 · 27 (2) · 930
DOI: 10.3390/ijms27020930 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.01.2026. Verfasst von Yasemin Ünal und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Faculty of Medicine, Bandırma Onyedi Eylül University, 10200 Balıkesir, Turkey. Hauptthemen laut MEDLINE: Parkinson Disease, MicroRNAs, Biomarkers, Gene Expression Regulation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bandırma Onyedi Eylül University.
Abstract (Originalsprache)
Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by dopaminergic neuronal loss and abnormal α-synuclein aggregation. Circulating microRNAs (miRNAs) have emerged as promising biomarkers and potential modulators of PD-related molecular pathways. In this study, we investigated the expression levels of four candidate miRNAs—miR-15a-5p, miR-16-5p, miR-139-5p, and miR-34a-3p—in patients with PD compared with healthy controls. A total of 47 PD patients and 45 age- and sex-matched controls were enrolled. Plasma miRNA levels were quantified using standardized RNA extraction, cDNA synthesis, and qPCR protocols. We observed marked upregulation of miR-15a-5p and robust downregulation of both miR-139-5p and miR-34a-3p in PD patients, whereas miR-16-5p showed no significant difference between groups. Target gene prediction and functional enrichment analysis identified 432 unique genes, with enrichment in biological processes related to protein ubiquitination and catabolic pathways, and signaling cascades such as mTOR, PI3K-Akt, MAPK, and Hippo pathways, all of which are implicated in neurodegeneration. Elevated miR-15a-5p may contribute to pro-apoptotic mechanisms, while reduced miR-139-5p and miR-34a-3p expression may reflect impaired mitochondrial function, diminished neuroprotection, or compensatory regulatory responses. Together, these dysregulated circulating miRNAs provide novel insight into PD pathophysiology and highlight their potential as accessible, non-invasive biomarkers. Further longitudinal studies in larger and more diverse cohorts are warranted to validate their diagnostic and prognostic value and to explore their utility as therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Faculty of Medicine, Bandırma Onyedi Eylül University, 10200 Balıkesir, Turkey.
- Department of Molecular Biology and Genetics, Graduate School of Natural and Applied Sciences, Muğla Sıtkı Koçman University, 48000 Muğla, Turkey.
- Department of Bioinformatics, Graduate School of Natural and Applied Sciences, Muğla Sıtkı Koçman University, 48000 Muğla, Turkey.
- Department of Medical Biology, Faculty of Medicine, Muğla Sıtkı Koçman University, 48000 Muğla, Turkey.
ORCID-Profile: Yasemin Ünal, Dilek Akbaş
Förderung
- Bandırma Onyedi Eylül University
Zitieren
APA
Ünal, Y., Akbaş, D., Özdemir, Ç., & Edgünlü, T. (2026). Dysregulated MicroRNAs in Parkinson’s Disease: Pathogenic Mechanisms and Biomarker Potential. International Journal of Molecular Sciences, 27(2), 930. https://doi.org/10.3390/ijms27020930
Vancouver
Ünal Y, Akbaş D, Özdemir Ç, Edgünlü T. Dysregulated MicroRNAs in Parkinson’s Disease: Pathogenic Mechanisms and Biomarker Potential. International Journal of Molecular Sciences. 2026;27(2):930. doi:10.3390/ijms27020930
BibTeX
@article{nal2026,
author = {Ünal, Yasemin and Akbaş, Dilek and Özdemir, Çilem and Edgünlü, Tuba},
title = {Dysregulated MicroRNAs in Parkinson’s Disease: Pathogenic Mechanisms and Biomarker Potential},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {2},
pages = {930},
doi = {10.3390/ijms27020930}
}
EUVIMED